Clinical efficacy of tanshinone capsules combined with varying concentrations of 5-ALA-PDT in the treatment of cystic acne.
Year: 2021
Type: article
Study design: Clinical Trial
Abstract: OBJECTIVE: To investigate the clinical effectiveness and safety of tanshinone capsules combined with varying concentrations of 5-aminoketovaleric acid photodynamic therapy (5-ALA-PDT) in the treatment of cystic acne. METHODS: A total of 97 patients with cystic acne treated in our hospital were enrolled in the study and divided into group A (n = 34, tanshinone capsules combined with 5% 5-ALA-PDT), group B (n = 31, tanshinone capsules combined with 7.5% 5-ALA-PDT), and group C (n = 32, tanshinone capsules combined with 10% 5-ALA-PDT). The number of skin lesions, the global acne grading system (GAGS) scores, the clinical effectiveness, the adverse reactions, and the recurrence rates were compared among the three groups. RESULTS: <0.05). CONCLUSIONS: Tanshinone capsules combined with 7.5% 5-ALA-PDT showed the optimal clinical effectiveness and safety in the treatment of cystic acne.
Source: PubMed Central
Institution: Nanjing University of Chinese Medicine
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3205396546